product summary
Loading...
company name :
Bio-Rad
other brands :
Biogenesis, Serotec, AbD Serotec, Oxford Biotechnology
product type :
other
product name :
READILINK™ 492/516 Antibody Labeling Kit
catalog :
1351002
quantity :
2 Conjugations For 50 µg Antibody
price :
272 USD
more info or order :
image
image 1 :
Bio-Rad 1351002 image 1
Efficient labelling of antibodies in two easy steps
product information
Entity Type :
Conjugation Kit
Entity Category :
Kits
ProductCode :
1351002
Description :
READILINK™ 492/516 Antibody Labeling Kit
Specificity :
READILINK™
Format :
492/516
Applications :
CJ
ApplicationTypes :
Conjugation
Quantity :
2 Conjugations For 50 µg Antibody
Quantity Value :
2
Quantity Type :
Conjugations For 50 µg Antibody
Entity Formats :
405/454,492/516,555/570,594/610,633/655,647/674,700/713
UNSPSC :
41116126
PriceGBP :
195
PriceEUR :
273
PriceUSD :
272 USD
PriceCHF :
297
PriceSEK :
3112
PriceNOK :
3108
PriceDKK :
2036
NotForSaleInCountries :
KR
more info or order :
company information
Bio-Rad
Endeavour House, Langford Business Park
Langford Lane, Kidlington
OXON, OX5 1GE
antibody_sales_uk@bio-rad.com
https://www.bio-rad-antibodies.com
1 800 265 7376 (North America)
44 (0)1865 852 700 (Rest of World)
headquarters: UK
Bio-Rad is one of the world's leading antibody manufacturers, offering over 12,000 antibodies and related reagents for a focused range of research areas such as immunology, cancer, veterinary research and cell biology through its antibody experts formerly known as AbD Serotec.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.